For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240712:nRSL1248Wa&default-theme=true
RNS Number : 1248W Smith & Nephew Plc 12 July 2024
SMITH & NEPHEW PLC
12 July 2024
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
On 11 July 2024, Smith & Nephew plc (the "Company") received notification
of the following transactions as detailed below.
Reason for the notification
Initial notification /Amendment Initial notification
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
Name Smith & Nephew plc
LEI 213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
Description of the financial instrument, type of instrument Smith & Nephew plc SPON ADR American Depositary Shares (ADS)
Identification code ISIN: US83175M2052
Nature of the transaction Purchase of American Depository Shares as participants of the Company's
Employee Stock Purchase Plan
Date of Transaction 2024-07-5
Place of Transaction New York Stock Exchange
Name Director / PDMR Price ($) Volume Aggregated information
Deepak Nath Director 21.06 465.54938 N/A Single Transaction
(Chief Executive Officer)
Paul Connolly PDMR 21.06 465.54938 N/A Single Transaction
(President, Global Operations)
Craig Gaffin PDMR 21.06 465.54938 N/A Single Transaction
(President, Global Orthopaedics)
Mizanu Kebede PDMR 21.06 108.48433 N/A Single Transaction
(Chief Quality & Regulatory Affairs Officer)
Scott Schaffner PDMR 21.06 261.92498 N/A Single Transaction
(President, Sports Medicine)
Helen Barraclough
General Counsel and Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLFERDAILLIS